FDA approves angiotensin II for distributive shock

The FDA approved angiotensin-II (Giapreza) as a new intravenous vasopressor for septic shock and other forms of distributive shock. The first new FDA-approved vasopressor in decades.
This is based on recent trial, which was discussed here.


Interferon Beta Tx Shows No Benefit in ARDS.Read more
%d bloggers like this: